ACTA2 Inhibitors

Common ACTA2 Inhibitors include, but are not limited to Forskolin CAS 66575-29-9, Y-27632, free base CAS 146986-50-7, SB 431542 CAS 301836-41-9, LY 294002 CAS 154447-36-6 and Rapamycin CAS 53123-88-9.

ACTA2, commonly known as alpha smooth muscle actin (α-SMA), is a protein that belongs to the actin family, which are highly conserved proteins that are involved in various types of cell motility. ACTA2 is particularly prevalent in vascular smooth muscle cells and is a key player in muscle contraction processes. The protein is crucial for maintaining the contractile function of smooth muscle tissue. It is also involved in various cellular functions such as cell motility, structure, and integrity. ACTA2's role is prominent in the formation of stress fibers, which are contractile structures found within non-muscle cells. Additionally, ACTA2 expression is often upregulated in myofibroblasts, a cell type that emerges during wound healing and tissue fibrosis.

ACTA2 inhibitors are compounds specifically designed to target and suppress the activity or expression of the ACTA2 protein. The inhibition of ACTA2 can influence the contractile capabilities of smooth muscle cells and modulate their phenotype. By targeting ACTA2, these inhibitors can alter cell motility, adhesion, and other processes where actin dynamics play a pivotal role. On a molecular level, ACTA2 inhibitors might function by disrupting the polymerization of ACTA2 or by preventing its incorporation into actin filaments. Moreover, these inhibitors could also interfere with the interaction between ACTA2 and other binding partners, thereby affecting the cellular functions in which these complexes are involved.